Emergency Information Take Over
Tuesday, September 29, 2015
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland. The annual meeting is attended by internationally renowned scientists and integrates a multidisciplinary program of basic research including finding a cure for HIV, innovating and guiding development of an effective preventive HIV vaccine, and the study of HIV pathogenesis, hepatitis C and Ebola. Scientists are focusing on viruses and cancer to inform basic and translational research aimed at developing treatments while clinical research presentations are emphasizing opportunities to cure hepatitis C with newly available treatments. Global health presentations are focusing on translating discovery into public health practice.
During a gala at the meeting tonight, two 2015 IHV Lifetime Achievement Awards for Scientific Contributions and Public Service will each be rewarded to Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases and Nobel Laureate Harald zur Hausen, MD.
“Each year, our annual meeting attracts many of the best and brightest established and up and coming researchers medical virology has to offer because of the high caliber data presented during these meetings,” said Robert C. Gallo MD, Homer & Martha Gudelsky Distinguished Professor in Medicine, Director, Institute of Human Virology, University of Maryland School of Medicine, who is most widely known for his co-discovery of HIV as the cause of AIDS and, along with his coworkers, for the development of the HIV blood test.
Dr. Gallo continued, “I am especially pleased to be honoring two distinguished friends and colleagues for their significant scientific contributions to bettering human health and for their impactful worldwide public service. Since the beginning of the HIV epidemic, Tony Fauci has led many research and education efforts that have contributed tremendously in putting an end to AIDS. He has administered a comprehensive research portfolio targeting the prevention, detection, and treatment of infectious diseases, which is not limited to HIV,” said Dr. Gallo. “Harald zur Hausen’s pioneering research in human papillomaviruses, most notably in showing the link between human papillomaviruses (HPV) and cervical cancer, has contributed greatly to fighting cancer. His discoveries helped lead to the development of the HPV vaccine.”
In 1996 Dr. Gallo co-founded the IHV with colleagues William Blattner, MD and Robert Redfield, MD. The Baltimore-based Institute has cared for more than 1,000,000 HIV positive individuals in 7 African and 2 Caribbean nations in addition to approximately 6,000 HIV positive Baltimoreans. IHV is internationally renowned for its basic science research, which includes the search for a functional cure and a promising preventive HIV vaccine candidate funded largely by the Bill & Melinda Gates Foundation.